1Rivkees SA. The treatment of Graves' disease in children[J]. J Pediatr Endoerinol Metab, 2006,19: 1095-1111. 被引量：1
2Cooper DS. Hyperthyroidism [J ]. Lancet, 2003,362 : 459-468. 被引量：1
3Kaguelidou F, Carel JC, Leger J. Graves' disease in childhood: advances in management with antithyroid drug therapy [J]. Horm Res,2009,71 (6) :310-317. 被引量：1
4Gruneiro-papendieck L, Chiesa A, Finkeilstain G, et al. Pediat- ric Graves ' disease:outcome and treatment [J]. J Pediatr Endo- crinol Metab, 2003,16 (9) : 1249-1255. 被引量：1
5Ginsberg J. Diagnosis and management of Grave' s disease [J]. CMAJ,2003,168(5) :575-585. 被引量：1
6Rivkees SA. Pediatric Graves' disease: controversies in man- agement [ J ]. Horm Res Paediatr, 2010,74: 305-311. 被引量：1
7Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use [J]. Int J Pediatr Endocrinol, 2009,2009 : 1-8. 被引量：1
8Abalovich M, Amino N, Barbour LA, et al. Management of thy- roid dysfunction during pregnancy and postpartum : an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2007,92($8) : 1-47. 被引量：1
9Bahn RS, Bureh HS, Cooper DS, et al. The role of propylthiouraoil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration[J]. Thyroid, 2009, 19 (7) :673-674. 被引量：1
10Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? [J]. Eur J Endocrinol, 2006,155 (6) : 783-786. 被引量：1
二级参考文献36
1Schott M,Eckstein A,Willenberg HS,et al.Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.Horm Metab Res,2007,39:56-61. 被引量：1
2Schott M,Minich WB,Willenberg HS,et al.Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.Horm Metab Res,2005,37:741-744. 被引量：1
3Izunri Y,Takeoka K,Amino N.Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiated relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.Endocr J,2005,52:493-497. 被引量：1
4Pedersen IB,Knudsen N,Perrild H,et al.TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre:a comparison of two competitive binding assays.Clin Endocrinol(Oxf),2001,55:381-390. 被引量：1
6Ferrara AM,Capalbo D,Rossi G,et al.A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations:a possible role of iodine supplementation.Thyroid,2007,17:677-680. 被引量：1
7Noh JY,Hamada N,Inoue Y,et al.Thyroid-stimulating antibody is related to Graves' ophthalmopathy,but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.Thyroid,2000,10:809-813. 被引量：1
8Eckstein AK,Plicht M,Lax H,et al.Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease.J Clin Endocrinol Metab,2006,91:3464-3470. 被引量：1
9Massart C,Sapin R,Gibassier J,et al.Intermethod variability in TSH-receptor antibody measurement:implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.Clin Chem,2009,55:183-186. 被引量：1
10Kim WB,Cho BY,Park HY,et al.Epitopes for thyroid stimulating antibodies in Graves' sera; a possible link of heterogeneity to differences in response to antithyroid drug treatment.J Clin Endocrinol Metab,1996,81:1758-1767. 被引量：1
7Cooper DS. Hyperthyroidism [J]. Lancet, 2003, 362(9382):459-460. 被引量：1
8Kaguelidou F, Carel JC, Leger J. Graves’ disease in child-hood: advances in management with antithyroid drug therapy[J]. HormRes, 2009, 71(6): 310-317. 被引量：1
9Gruneiro-papendieck L, Chiesa A, Finkeilstain G, et al. Pe-diatric Graves' disease: outcome and treatment [J]. J PediatrEndocrinol Metab, 2003’ 16(9): 1249-1255. 被引量：1
10Rivkees SA, Dinauer C. An optimal treatment for pediatricGraves' disease is radioiodine [J]. J Clin Endocrinol Metab,2007, 92(3): 797-800. 被引量：1
